2026 American Society of Clinical Oncology (ASCO) Annual MeetingInhibrx Reports Interim Phase 2 Data for INBRX-106 in First-Line HNSCC (ASCO 2026 INBRX-109 CRC Data Update[...]

Inhibrx Biosciences Inc. published this content on May 19, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 30, 2026 at 16:44 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]